Adolore BioTherapeutics to Present at the 5th Annual National Institutes of Health (NIH) HEAL Initia
DELRAY BEACH, FL / ACCESSWIRE / January 30, 2024 / Adolore BioTherapeutics ("Adolore" or the "Company"), a biotechnology company focused on developing breakthrough opioid-free gene therapy treatments for chronic pain, today announced that Roy C. Levitt, MD, the Company's founder and Executive Cha...
United States National Institutes Of Health University Of Miami Delray Beach Jenene Thomas Adolore Biotherapeutics
Source: pharmiweb.com